“Game-changing” antibody cocktail prevents COVID-19 in the chronically ill
A new monoclonal antibody treatment has been found to protect chronically ill adults from developing COVID-19. The Phase 3 trial results suggest the novel antibody cocktail, delivered by intramuscular injection, could offer up to 12 months protection. Source of Article